The patch-clamp technique was used to study the 
R ecently, considerable attention has been paid to a group of agents -which includes cromakalim (BRL 34915), nicorandil, and pinacidil -because of their unique abilities to produce a potent vasodilatory action and to promote action on the potassium channel of vascular smooth muscle cells. Because of the latter action, these agents are called potassium channel openers.' All of these agents also affect cardiac membranes to shorten the action potential duration (APD) and, sometimes, to hyperpolarize the resting membrane potential.2-5 Therefore, they are assumed to modulate the potassium channel activity of cardiac membranes as well. An actual target of potassium channel openers has not been known until recently, when two of them, cromakalim and nicorandil, were shown with the single-channel recording technique6,7 to activate the ATP-sensitive K' channel current (IK.ATP) of ventricular myocytes. As pinacidil has an effect similar to the others on the APD' and the background potassium current,8 its target is assumed to be the same K' channel. Indeed, Arena and Kass9 showed that pinacidil activated the time-and voltageindependent outward K' current, which was blocked by glibenclamide, a potent blocker of IKATP. [10] [11] [12] [13] From these observations, they suggested that the target for pinacidil in the heart is IK.ATP. A preliminary study by Escande et al14 with the single-channel recording technique indicated that pinacidil activated this channel, but the detailed mechanism of its action on IKATP remains unclear.
The ATP-sensitive K' channel is characterized by a strong inhibition of activity when the intracellular 
Preparation
Single ventricular myocytes were isolated from both ventricles of adult guinea pigs that weighed 250-350 g. Our technique to isolate single myocytes has been described in a previous report. 16 
Solutions
The composition of Tyrode's solution was (mM) NaCI 144, NaH2PO4 0.33, KCl 4.0, CaCl2 1.8, MgCl2 0.53, glucose 5.5, and HEPES 5.0, with pH adjusted to 7.3-7.4 by addition of NaOH. The high K+ low Cl-solution had the following composition (mM): glutamic acid 70, taurine 15, KCl 30, KH2P04 10, MgCl2 0.5, glucose 11, EGTA 0.5, and HEPES 10, with pH adjusted to 7.4 by addition of KOH. Pinacidil, a gift of Shionogi Pharmaceutical Co. (Osaka, Japan), was dissolved as a stock solution in 1% 0.1N HCl and diluted appropriately before study. Glibenclamide, a gift of Hoechst Japan (Tokyo), was dissolved as 0.2 mM stock solution in 2% dimethyl sulfoxide (DMSO) and diluted into the test solution to obtain the final concentration indicated in the text. The final concentration of DMSO contained in the test solution was less than 0.01%.
Whole-Cell Current Recordings
The patch-clamp technique of the whole-cell configuration17 was used to record membrane potentials and currents by using a patch-clamp amplifier (model 8900, Dagan Corp., Minneapolis). Details of the recording technique and the data-acquisition systems are described in our previous reports.7 ' Series resistance compensation was adjusted to minimize the duration of the capacitive surge on the current trace. At the end of each experiment, liquid junction potential was checked, and if more than +2 mV, the value of the membrane potential was corrected accordingly. The temperature of the perfusion chamber was maintained at 33-35°C. The solution in the chamber flowed continuously by gravity with a speed of 1.2-1.5 ml/min. The chamber volume of 0.8 ml was completely exchanged 1 minute after a solution change. Control data were taken 5 minutes after changing to the appropriate solution. Drug effects were tested 5-10 minutes after the drug-containing solution was changed.
Single-Channel Current Recordings
Single-channel current recordings were made at room temperature in the inside-out patch configuration'7 with the same patch-clamp amplifier used in the whole-cell experiments. Currents and voltage signals were recorded with a videocassette recorder (HR-S 5500, Victor Co., Tokyo) through a pulse code modulation converting system (RP-882, NF Instruments). Recorded signals were filtered off-line through an eight-pole Bessel low-pass filter (48 dB/ octave, FV-665, NF Instruments) at 500 Hz and digitized at 5 kHz using an analog-to-digital convertor (CED 1401, Cambridge Electronic Design Ltd., Cambridge, UK) to store into the disk of an IBM-AT personal computer for later analysis. When the single-channel recording with the inside-out patch configuration was done, the bath solution (intracellular solution) contained Figure 2A illustrates membrane current responses to depolarizing or hyperpolarizing voltage steps from the holding potential of -30 mV before and during the application of 10 ,uM pinacidil using a pipette solution containing 2 mM ATP. Pinacidil increased outward current at a potential positive to around -80 mV, and this increase was time-independent. At potentials negative to -90 mM, pinacidil decreased inward current during pulses (see "Discussion"). The steady-state current-voltage relation, in which current was measured at the end of the 2-second test pulses, showed increased outward current with a loss of negative slope region at voltages between -60 and -20 mV ( Figure 2B ). There was no change in the reversal potential. Similar results as shown in Figure  2 were confirmed in four cells, although the 
Block of the Pinacidil-Induced Changes in Membrane Potential and Current by Glibenclamide
We examined the effects of glibenclamide on the changes in action potentials and outward current induced by pinacidil because Arena and Kass9 described the suppression of the pinacidil-activated current by glibenclamide. Figure 6A completely suppressed by 0.3 jM glibenclamide (Figure 7 ). This result was confirmed in three myocytes.
Effect of Pinacidil on the Single-Channel Current
The effect of pinacidil on the single-channel current was studied using the inside-out patch configurations. Figure 8 shows a typical example of the records at a membrane potential of +40 mV ( Figure  8A ), as well as amplitude histograms ( Figure 8B pinacidil increases PO of the ATP-sensitive K' channel, which explains the shortening of APD of heart cells after drug treatment. Pinacidil has been shown to shorten the APD of heart muscles and to modify the shape of the T wave on surface electrocardiograms. The effects are attributed to an increase in K' permeability of cardiac membranes.5,21 lijima and Taira8 actually showed an increase in the outward current using isolated ventricular myocytes, and they interpreted this action as an activation of the background K' current. Arena and Kass9 recently explored the target of the membrane current system activated by pinacidil and confirmed that pinacidil actually activated the K' current in guinea pig ventricular myocytes, but they interpreted the pinacidil-activated current as IK.ATP on the basis of its time-and voltage-independent properties, as well as its pharmacological characteristics. IK.ATP itself and may lead to an understanding of the basic mechanism of the drug action on the heart. Pinacidil would be expected to be more effective in the ischemic heart than in the normal heart, because the ischemic heart would have less [ATP] i than the normal. Whether or not the action of pinacidil could bring about beneficial effects for the function of the ischemic heart is to be evaluated further.
